SCHEMBL225546

SCHEMBL225546

O=C(O)Cc1ccc(SSc2ccc(CC(=O)O)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.60
CAMK2A Q9UQM7 1/20 0.60
AKR1B1 P15121 1/20 0.58
LMNA P02545 2/20 0.56
GAA P10253 2/20 0.56
TSHR P16473 2/20 0.56
ABCC4 O15439 1/20 0.56
PTGS1 P23219 1/20 0.56
HTT P42858 1/20 0.56
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 3/20 0.50
FFAR1 O14842 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 3/20 0.48
NSD2 O96028 1/20 0.48
GRK2 P25098 1/20 0.48
CASP6 P55212 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22415047 0.94 AKR1B1 (0.64) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL3767923 0.87 CA2 (0.52) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL13464286 0.86 CA2 (0.60) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL21654480 0.85 CA2 (0.46) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL69614 0.84 CA2 (0.79) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL8362761 0.84 CA2 (0.58) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL19401304 0.84 KDM4E (0.49) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL21512167 0.82 CA2 (0.56) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL7406010 0.82 CA2 (0.56) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL46640 0.82 CA2 (0.56) CA2CAMK2AAKR1B1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5342724-A Preparing polyester from diol and diacid wherein one of the monomers has disulfuide linkage, reacting polyester with unsaturated monomer to create addition polymer blocks linked by sulfide group from dislufide linkage EASTMAN KODAK COMPANY (US) 1994-08-30 US claimed
US-20260055241-A1 STORAGE AND RELEASE OF BIOMOLECULES CACHE DNA INC (US) 2026-02-26 US disclosed
WO-2024177717-A1 STORAGE AND RELEASE OF BIOMOLECULES CACHE DNA, INC. (US) 2024-08-29 WO disclosed
US-20210227827-A1 METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION NEW YORK BLOOD CENTER, INC. 2021-07-29 US disclosed
WO-2020023881-A1 METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION ZATA PHARMACEUTICALS, INC. (US) 2020-01-30 WO disclosed
US-10172938-B2 Multimode degradable hydrogels for controlled release of cargo substances UNIVERSITY OF DELAWARE (US) 2019-01-08 US disclosed
US-20170258907-A1 MULTIMODE DEGRADABLE HYDROGELS FOR CONTROLLED RELEASE OF CARGO SUBSTANCES UNIVERSITY OF DELAWARE (US) 2017-09-14 US disclosed
WO-2015168090-A1 MULTIMODE DEGRADABLE HYDROGELS FOR CONTROLLED RELEASE OF CARGO SUBSTANCES KIICK KRISTI L (US) 2015-11-05 WO disclosed
EP-2410019-A1 POLYAMIDE RESIN COMPOSITION, FILM COMPRISING SAME, AND LAMINATED POLYAMIDE FILM Ube Industries, Ltd. (JP) 2012-01-25 EP disclosed
US-20120003361-A1 POLYAMIDE RESIN COMPOSITION, FILM COMPRISING THE SAME AND POLYAMIDE-BASED LAMINATE FILM UBE INDUSTRIES, LTD. (JP) 2012-01-05 US disclosed
EP-0393574-B1 Hexitol derivatives KYOWA HAKKO KOGYO KK (JP) 1996-01-31 EP disclosed
US-5342724-A Preparing polyester from diol and diacid wherein one of the monomers has disulfuide linkage, reacting polyester with unsaturated monomer to create addition polymer blocks linked by sulfide group from dislufide linkage EASTMAN KODAK COMPANY (US) 1994-08-30 US disclosed
US-5053408-A Cardiovascular disorders KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-10-01 US disclosed
EP-0393574-A2 Hexitol derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1990-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055241-A1 STORAGE AND RELEASE OF BIOMOLECULES EXOC1, EXOC3, DNTT CA2 1342/4885CAMK2A 783/4885AKR1B1 4711/4885
US-20210227827-A1 METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION MGMT, O60361, SAMHD1 CA2 1446/4885CAMK2A 4798/4885AKR1B1 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.